Daclatasvir

CAS 1009119-64-5

Em Estoque

Daclatasvir

Cat. No. STUB-API-DACLATASVIRCAS 1009119-64-5Em Estoque

Dados Técnicos

Cat. No.STUB-API-DACLATASVIR

CAS1009119-64-5

Fórmula Mol.C₄₀H₅₀N₈O₆

Peso Mol.738.89 g/mol

IUPACmethyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

SMILESCC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC

InChIInChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1

Chave InChIFKRSSPOQAMALKA-CUPIEXAXSA-N

Pureza—

Descrição

Visão geral

Daclatasvir, sold under the trade name Daklinza, is a medication used in combination with other medications to treat hepatitis C. The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis

A Anant Labs fabrica e fornece impurezas de Daclatasvir de alta qualidade para o mercado global. Nossas impurezas EP de Daclatasvir são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Sinônimos

Daclatasvir1009119-64-5BMS-790052BMS790052BMS 790052EBP 883Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl estermethyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamateEBP-883LI2427F9CI

Buscar APIs A–Z